SCHEMBL9876539

SCHEMBL9876539

N=C(NCCCc1c[nH]cn1)NCCSCc1ccncc1

nearest known ligand 0.38

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.38
CYP2D6 P10635 3/20 0.38
CYP2C9 P11712 3/20 0.38
CYP2C19 P33261 3/20 0.38
CYP3A4 P08684 2/20 0.38
SMN1; SMN2 Q16637 3/20 0.36
ALPG P10696 2/20 0.36
HTT P42858 2/20 0.36
ALPL P05186 1/20 0.36
ALPI P09923 1/20 0.36
LMNA P02545 2/20 0.34
ALDH1A1 P00352 4/20 0.32
HPGD P15428 2/20 0.32
GAA P10253 1/20 0.32
NPSR1 Q6W5P4 1/20 0.30
DAO P14920 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9867335 0.88 EPHX2 (0.35) SMN1; SMN2LMNAALDH1A1HPGDDAO
SCHEMBL9868517 0.88 KMT2A (0.42) CYP1A2CYP2D6CYP2C9CYP2C19CYP3A4
SCHEMBL9866034 0.88 ALDH1A1 (0.45) SMN1; SMN2HTTLMNAALDH1A1HPGD
SCHEMBL9865256 0.85 ALDH1A1 (0.45) SMN1; SMN2HTTLMNAALDH1A1GAA
SCHEMBL7180733 0.84 LMNA (0.37) CYP1A2SMN1; SMN2HTTLMNAALDH1A1
SCHEMBL9867267 0.83 LMNA (0.35) CYP1A2CYP2D6CYP2C9CYP2C19CYP3A4
SCHEMBL9865647 0.83 GAA (0.45) CYP1A2CYP2D6CYP2C9CYP2C19SMN1; SMN2
SCHEMBL9864976 0.83 KMT2A (0.36) SMN1; SMN2HTTALDH1A1HPGD
SCHEMBL7174490 0.82 ALDH1A1 (0.32) ALDH1A1
SCHEMBL9876542 0.82 HRH4 (0.39) CYP1A2CYP2D6CYP2C9CYP2C19CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5021431-A H-1 antagonist, h-2 agonist for treating hypertension, cardiac disease or arterial occlusion HEUMANN PHARMA GMBH & CO. (DE) 1991-06-04 US disclosed
EP-0199845-A1 Imidazolylalkylguanidin derivatives, process for their preparation and pharmaceutical compositions containing them HEUMANN PHARMA GMBH & CO (DE) 1986-11-05 EP disclosed